Adiponectin protects against Angiotensin II-induced cardiac fibrosis and left ventricular dysfunction through an AMPK-dependent PPAR-α activation pathway.
No takes yet. Share an insight, caveat, or question.
Adiponectin-PPAR-α effects in Ang II fibrosis models extend mechanistic insight; leaves open human translation.
Fujita et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: